PubRank

Salim S Abdool Karim

Author PubWeight™ 58.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002 11.02
2 Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol 2008 5.24
3 Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS 2003 4.87
4 HIV prevention transformed: the new prevention research agenda. Lancet 2011 4.23
5 Dual HIV-1 infection associated with rapid disease progression. Lancet 2004 2.17
6 Uptake of provider-initiated HIV testing and counseling among women attending an urban sexually transmitted disease clinic in South Africa - missed opportunities for early diagnosis of HIV infection. AIDS Care 2010 2.08
7 Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. J Clin Invest 2012 2.05
8 Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS 2010 1.94
9 Enrolling adolescents in research on HIV and other sensitive issues: lessons from South Africa. PLoS Med 2006 1.90
10 Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial. Trials 2011 1.15
11 Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet Gynecol 2011 1.13
12 Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin. Virology 2010 1.13
13 Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. Clin Infect Dis 2011 1.09
14 Utilizing nucleic acid amplification to identify acute HIV infection. AIDS 2007 1.07
15 Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial. Contemp Clin Trials 2011 1.04
16 Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. J Virol 2010 1.02
17 Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial. AIDS Behav 2014 1.00
18 CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck. J Infect Dis 2012 0.99
19 Changes in Natural Killer cell activation and function during primary HIV-1 Infection. PLoS One 2013 0.96
20 Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial. Antivir Ther 2012 0.94
21 Sustainability of task-shifting for antiretroviral treatment. Lancet 2012 0.87
22 Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS Care 2014 0.87
23 HIV infection in high school students in rural South Africa: role of transmissions among students. AIDS Res Hum Retroviruses 2014 0.86
24 Antiretroviral prophylaxis for HIV prevention reaches a key milestone. Lancet 2012 0.85
25 Apnea and its possible relationship to immunization in ex-premature infants. Vaccine 2008 0.84
26 Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models. Virol J 2013 0.82
27 HIV incidence estimates are key to understanding the changing HIV epidemic in South Africa. S Afr Med J 2007 0.81
28 Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women. AIDS 2016 0.80
29 Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial. Antivir Ther 2013 0.80
30 HIV prevalence among high school learners - opportunities for school-based HIV testing programmes and sexual reproductive health services. World Health Popul 2012 0.78
31 Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection. Virol J 2008 0.78
32 Increasing burden of pulmonary tuberculosis in young women. S Afr Med J 2006 0.78
33 Re: "Enhancement of HIV infection by cellulose sulfate," by Tao et al. AIDS Res Hum Retroviruses 2009 0.76
34 Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial. AIDS Behav 2014 0.76
35 Scientists stand by decision to join Mbeki's AIDS panel. Nature 2009 0.75
36 Report from the Tenth Retrovirus Conference. Vaccines and microbicides. AIDS Clin Care 2003 0.75